Target intelligence / Profile preview

Type III secretion system protein (T3SS protein)

Target
T3SS protein
Molecular classification
Other (Bacterial virulence nanomachine protein complex), Transporter (secretion/export), Structural protein (complex-forming), Enzyme (ATPase subunit)
01

Overview

Type III secretion system protein refers collectively to the integrated set of highly conserved proteins composing the Type III secretion system (T3SS), a syringe-like nanomachine utilized by many Gram-negative pathogenic bacteria to inject virulence effector proteins directly into the cytoplasm of eukaryotic host cells[1][2][3][4][7][8]. The T3SS itself is made up of over 20 structural and functional protein components forming the needle complex (basal body, needle, export apparatus, and sorting platform), as well as several auxiliary chaperones and ATPases required for the energy-dependent export of unfolded effector proteins. These proteins play a critical role in bacterial pathogenicity by facilitating colonization, immune evasion, and manipulation of host cell function, and are fundamentally required for the infectivity of pathogens such as *Salmonella*, *Shigella*, *Yersinia*, *Pseudomonas*, and pathogenic *Escherichia coli*[1][3][4][5][6][7][8]. Due to their essential role in disease, T3SS proteins are recognized as promising antibacterial targets, though no specific drugs have reached clinical approval as of yet. **Note:** - "Type III secretion system protein" is not a single protein but a class representing components of the secretion system complex[7][8]. - Individual core proteins (e.g., the needle protein, ATPase, chaperones) may be drug targets, but often literature refers to the system collectively as a virulence apparatus[1][4][8]. - If you require a specific T3SS subunit (e.g., "Type III secretion needle protein"), please specify for more granular information.

Other names
Type III secretion apparatus proteinInjectisome proteinT3SA protein
02

Mechanism of action

Inhibition of T3SS assembly Blockade of effector protein secretion Inhibition of T3SS ATPase activity Targeting the needle protein or basal body interaction

03

Biological functions

Protein export (translocation of bacterial effector proteins)Bacterial virulence and infectionSuppression of host immune responseManipulation of host cytoskeleton
04

Disease associations

Infection (pathogenic bacteria such as *Salmonella*, *Shigella*, *Yersinia*, *Pseudomonas*)Other (bacterial pathogenesis and inflammation)
05

Safety considerations

Potential for off-target effects on commensal microbiota expressing similar mechanisms[4].Resistance development due to selective pressure.T3SS inhibitors may not address already established infections or secreted toxins.
06

Interacting drugs

No clinically approved drugs directly target T3SS proteins, but experimental inhibitors (e.g., small molecule T3SS inhibitors) are under investigation[4][8].

1 more in the full profile.

07

Biomarkers

Presence of T3SS-dependent effector proteins in infected host tissue can act as a biomarker for certain bacterial infections[4][8].Genes encoding T3SS components can be diagnostic for some Gram-negative pathogens.

Beyond the preview

Go deeper on Type III secretion system protein (T3SS protein).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Type III secretion system protein (T3SS protein).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call